Valeant Recent News
Bill Ackman Is Killin' It In Chipotle
Gadfly's Nisen: Valeant's 'Financial Wizardry' Doesn't Change The Long-Term Outlook
Valeant's Post-Ackman Recovery Is Characterized By 'Less Money, More Problems'
Valeant: Traders Vs. Portfolio Managers
Pershing Square Defends Valeant's Progress, Can't Defend Its Stock Performance
Valeant's Asset Sale To L'Oreal Explained
Valeant's Laundry List: Products, Divestitures And Debt Load
Valeant Shares Carry Too Much Risk To Be Recommended As An Investment: Wells Fargo
Bill Ackman's Pershing Square Releases Q3 Letter To Shareholders
Criminal Charges Against Former Valeant Exec 'Not Pertinent But Underscores Cautious Outlook'
Is Allergan Going After Valeant's Eye Surgery Assets?
Analysts Having Difficulty Getting Comfortable With Valeant's Fundamentals
What Did Valeant Look Like Last Time The Stock Was Under $15?
A Deeper Look Into Valeant's Assets As It Searches For Salix Buyer
Valeant's Salix Story: To Sell Or Not To Sell?
Ackman: Valeant Doesn't Have To Sell Core Assets
Valeant Management On Q1 Call: 'We Don't Feel We Can Accurately Predict' GAAP Earnings
Can Broadcom Or Medtronic Offer Up An Earnings Surprise?
Report: Valeant Rejected A Takeover Offer Prior To Hiring Papa As CEO
Piper Jaffray Analyst: Latest Report On Valeant 'Doesn't Surprise Me'
Valeant's Price Cut To Hospitals Just Lip Service?
Ackman: Valeant Made Some Mistakes, But It's Not A Sewer
Senator Calls Out Bill Ackman, Questions His Senate Hearing Comments On Drug Pricing